Literature DB >> 17952118

DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.

A Vilgelm1, J X Wei, M B Piazuelo, M K Washington, V Prassolov, W El-Rifai, A Zaika.   

Abstract

The p73 protein is a transcription factor and member of the p53 protein family that expresses as a complex variety of isoforms. DeltaNp73alpha is an N-terminally truncated isoform of p73. We found that DeltaNp73 protein is upregulated in human gastric carcinoma suggesting that DeltaNp73 may play an oncogenic role in these tumors. Although it has been shown that DeltaNp73alpha inhibits apoptosis and counteracts the effect of chemotherapeutic drugs, the underlying mechanism by which this p73 isoform contributes to chemotherapeutic drug response remains to be explored. We found that DeltaNp73alpha upregulates MDR1 mRNA and p-glycoprotein (p-gp), which is involved in chemotherapeutic drug transport. This p-gp upregulation was accompanied by increased p-gp functional activity in gastric cancer cells. Our data suggest that upregulation of MDR1 by DeltaNp73alpha is mediated by interaction with p53 at the MDR1 promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952118      PMCID: PMC4066670          DOI: 10.1038/sj.onc.1210862

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1.

Authors:  Z Hu; S Jin; K W Scotto
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Transcriptional repression by p53 through direct binding to a novel DNA element.

Authors:  R A Johnson; T A Ince; K W Scotto
Journal:  J Biol Chem       Date:  2001-05-11       Impact factor: 5.157

3.  The gastrin gene promoter is regulated by p73 isoforms in tumor cells.

Authors:  K Tomkova; W El-Rifai; A Vilgelm; M C Kelly; T C Wang; A I Zaika
Journal:  Oncogene       Date:  2006-04-24       Impact factor: 9.867

4.  Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.

Authors:  Robert A Johnson; Erica M Shepard; Kathleen W Scotto
Journal:  J Biol Chem       Date:  2005-01-05       Impact factor: 5.157

Review 5.  Outcomes of p53 activation--spoilt for choice.

Authors:  Karen H Vousden
Journal:  J Cell Sci       Date:  2006-12-15       Impact factor: 5.285

6.  Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.

Authors:  Nicole Concin; Gerda Hofstetter; Astrid Berger; Adriana Gehmacher; Daniel Reimer; Rafal Watrowski; Dan Tong; Eva Schuster; Lukas Hefler; Kurt Heim; Elisabeth Mueller-Holzner; Christian Marth; Ute M Moll; Alain G Zeimet; Robert Zeillinger
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

7.  Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

Authors:  I Fillippovich; N Sorokina; M Gatei; Y Haupt; K Hobson; E Moallem; K Spring; M Mould; M A McGuckin; M F Lavin; K K Khanna
Journal:  Oncogene       Date:  2001-01-25       Impact factor: 9.867

8.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

9.  An anti-apoptotic role for the p53 family member, p73, during developmental neuron death.

Authors:  C D Pozniak; S Radinovic; A Yang; F McKeon; D R Kaplan; F D Miller
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

10.  DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

Authors:  Gemma Domínguez; José M García; Cristina Peña; Javier Silva; Vanesa García; Lara Martínez; Constanza Maximiano; María E Gómez; José A Rivera; Carmen García-Andrade; Felix Bonilla
Journal:  J Clin Oncol       Date:  2005-12-27       Impact factor: 44.544

View more
  21 in total

1.  Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma.

Authors:  Valentina Caracciolo; Marcella Macaluso; Luca D'Agostino; Micaela Montanari; Jonathan Scheff; Krzysztof Reiss; Kamel Khalili; Antonio Giordano
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

3.  Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.

Authors:  A E Vilgelm; S-M Hong; M K Washington; J Wei; H Chen; W El-Rifai; A Zaika
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

4.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

5.  Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells.

Authors:  Jinxiong Wei; Toni A Nagy; Anna Vilgelm; Elena Zaika; Seth R Ogden; Judith Romero-Gallo; Maria B Piazuelo; Pelayo Correa; Mary K Washington; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

Review 6.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

Review 7.  Therapeutic targeting of the p53 pathway in cancer stem cells.

Authors:  Varun V Prabhu; Joshua E Allen; Bo Hong; Shengliang Zhang; Hairong Cheng; Wafik S El-Deiry
Journal:  Expert Opin Ther Targets       Date:  2012-09-24       Impact factor: 6.902

Review 8.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

9.  Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors.

Authors:  Anna E Vilgelm; Mary K Washington; Jinxiong Wei; Heidi Chen; Vladimir S Prassolov; Alexander I Zaika
Journal:  Mol Cancer Ther       Date:  2010-03-02       Impact factor: 6.261

10.  Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Authors:  Joshua E Allen; Lori S Hart; David T Dicker; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2009-11-27       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.